An ex-con is taking his debt-ridden, cash-burning biotech public. Why are people investing?
The biotech company Kadmon is drowning in red ink. So how can it be valued at $700 million? Its charismatic founder, who's both admired and hated.
https://www.statnews.com/2016/07/26/kadmon-sam-waksal-biotech-scandal/